Press release
Illumina Names Joydeep Goswami Senior Vice President of Corporate Development and Strategic Planning
SAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (Nasdaq:ILMN) today announced the appointment of Joydeep Goswami as Senior Vice President of Corporate
About this update from Illumina, Inc.
[{"type":"text","content":" SAN DIEGO--(BUSINESS WIRE)--\nIllumina, Inc. (Nasdaq:ILMN) today announced the appointment of Joydeep Goswami as Senior Vice President of Corporate Development and Strategic Planning. Mr. Goswami will be responsible for driving planning, strategic partnerships and acquisitions, and will report to President and Chief Executive Officer, Francis deSouza.\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190923005311/en/Joydeep Goswami, Illumina Senior Vice President of Corporate Development and Strategic Planning (Photo: Business Wire)\n\nWith more than 20 years of global experience, Mr. Goswami has a strong track record of developing strategy and leading new product development, partnerships, licensing, and mergers and acquisitions. Most recently, he served as the President of Thermo Fisher Scientific’s Clinical Next-Generation Sequencing (NGS) and Oncology business unit, where he oversaw efforts that drove the adoption of NGS in clinical oncology, research and reproductive health.\n\n\n“We are very pleased to welcome Joydeep to Illumina,” said deSouza. “Joydeep’s global experience, entrepreneurial spirit and deep background in research and clinical businesses, will serve Illumina well as we accelerate the adoption of sequencing in existing markets and enable the most impactful, new opportunities for genomics.”\n\n\n\"I am honored to be joining Illumina and look forward to helping harness the power of the genome to shift the paradigm of healthcare and life science research across the globe,\" said Goswami.\n\n\nMr. Goswami has held senior leadership roles across the pharma/biotech, diagnostics and research tool continuum, previously serving at companies such as Life Technologies and Invitrogen, in addition to Thermo Fisher Scientific. He has led teams across various functions, including sales, marketing, R&D and other support functions. Mr. Goswami served as President, Asia Pacific and Japan while at Thermo Fisher Scientific and created the Stem Cells and Regenerative Medicine Business Unit at Invitrogen. Additionally, he spent five years at McKinsey & Co., where he specialized in strategy for pharmaceutical, medical technology and technology companies.\n\n\nMr. Goswami holds his M.S., Ph.D. in Chemical Engineering, an MBA from the Massachusetts Institute of Technology a...